HBM (Lux) Funds - HBM Global Biotechnology Fund A Fonds
120,63
EUR
-6,92
EUR
-5,43
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| argenx SE | NL0010832176 | 6,00% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 5,30% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,83% |
| Ascendis Pharma AS ADR | US04351P1012 | 4,68% |
| Gilead Sciences Inc | US3755581036 | 4,51% |
| Merus NV | NL0011606264 | 4,28% |
| Xenon Pharmaceuticals Inc | CA98420N1050 | 4,24% |
| Madrigal Pharmaceuticals Inc | US5588681057 | 4,10% |
| Arcutis Biotherapeutics Inc Ordinary Shares | US03969K1088 | 3,80% |
| Amgen Inc | US0311621009 | 3,78% |
| Sonstige | 54,49% |